874 Stock Overview
Researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People’s Republic of China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$18.46 |
| 52 Week High | HK$24.20 |
| 52 Week Low | HK$16.62 |
| Beta | 0.55 |
| 11 Month Change | -13.94% |
| 3 Month Change | -7.70% |
| 1 Year Change | -13.74% |
| 33 Year Change | -3.05% |
| 5 Year Change | -27.18% |
| Change since IPO | -30.47% |
Recent News & Updates
Recent updates
Shareholder Returns
| 874 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | -2.1% | -1.5% | -1.0% |
| 1Y | -13.7% | -23.5% | 15.0% |
Return vs Industry: 874 exceeded the Hong Kong Healthcare industry which returned -23.5% over the past year.
Return vs Market: 874 underperformed the Hong Kong Market which returned 15% over the past year.
Price Volatility
| 874 volatility | |
|---|---|
| 874 Average Weekly Movement | 6.2% |
| Healthcare Industry Average Movement | 8.4% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in HK Market | 19.0% |
| 10% least volatile stocks in HK Market | 4.3% |
Stable Share Price: 874 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 874's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 28,760 | Hong Li | www.gybys.com.cn |
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People’s Republic of China and internationally. The company operates through Great Southern TCM, Great Commerce, Great Health, and Other segments. It is also involved in the wholesale, retail, sale, import, and export of Western and Chinese medicines, medical instruments, pharmaceutical products, medical equipment, and healthcare products; and research and development, production, and sale of beverages, food, healthcare products, and other products; and production and sale of pre-packaged food, dairy products, etc., as well as offers herbal tea, tablets, capsules, lozenges, tortoise herb jelly, etc. In addition, the company invests in health industry, such as medical services, health management, health maintenance, elderly care, etc.; and provides leasing and commercial, health, advertising, loading offloading, and warehouse services.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Fundamentals Summary
| 874 fundamental statistics | |
|---|---|
| Market cap | HK$47.59b |
| Earnings (TTM) | HK$3.75b |
| Revenue (TTM) | HK$83.72b |
8.0x
P/E Ratio0.4x
P/S RatioIs 874 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 874 income statement (TTM) | |
|---|---|
| Revenue | CN¥76.39b |
| Cost of Revenue | CN¥63.46b |
| Gross Profit | CN¥12.93b |
| Other Expenses | CN¥9.50b |
| Earnings | CN¥3.42b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.11 |
| Gross Margin | 16.92% |
| Net Profit Margin | 4.48% |
| Debt/Equity Ratio | 35.5% |
How did 874 perform over the long term?
See historical performance and comparisonDividends
4.7%
Current Dividend Yield55%
Payout RatioDoes 874 pay a reliable dividends?
See 874 dividend history and benchmarks| Guangzhou Baiyunshan Pharmaceutical Holdings dividend dates | |
|---|---|
| Ex Dividend Date | Oct 15 2024 |
| Dividend Pay Date | Nov 15 2024 |
| Days until Ex dividend | 21 days |
| Days until Dividend pay date | 10 days |
Does 874 pay a reliable dividends?
See 874 dividend history and benchmarks